Viewing nowCombinationExfin Tablet 5/80 mg (Amlodipine Besylate, Valsartan)
Valsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.

MFDS item code 201404970 · Approved 2014.10.27 · Insurance code 628900290
Treatment of essential hypertension inadequately controlled with monotherapy
In cases where essential hypertension is not adequately controlled with either amlodipine or valsartan monotherapy, the combination of these two medications can achieve more effective blood pressure reduction. This combination helps manage blood pressure reliably and reduces the risk of cardiovascular diseases. Therefore, combination therapy may be used in the treatment of essential hypertension.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time every day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before treatment with this drug. However, a direct switch to this drug may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows. ㆍ5/80 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer this drug to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Exercise caution when increasing the dose.
The administration of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and neonate if taken during the second and third trimesters of pregnancy, and should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to any of the ingredients in this medication, pregnant or nursing women, those with severe kidney or liver diseases, and patients with certain heart conditions should avoid using this medication. Patients with insufficient sodium or fluid levels in their body may experience hypotension, so it's important to check their condition thoroughly before use and to monitor blood pressure changes carefully during treatment. Patients with high potassium levels should frequently check their potassium levels if they are taking this medication alongside potassium-increasing medications. Patients with vascular issues in the kidneys or those who have received kidney transplants should be cautious as this medication may affect kidney function. If symptoms of angioedema, such as swelling of the face, lips, or tongue, occur, discontinue the medication immediately and do not take it again. Patients with heart failure or those recovering from myocardial infarction should monitor kidney function and blood pressure closely while taking this medication. Patients with acute myocardial infarction or certain heart valve diseases should also be cautious when taking this medication. The risk of hypotension, worsening kidney function, and hyperkalemia may increase when this medication is used in combination with other blood pressure-lowering medications, so blood pressure and kidney function should be monitored frequently. Dizziness or fatigue may occur while driving or operating machinery, so caution is advised. In cases of overdose, severe hypotension or cardiac dysfunction may result, necessitating immediate medical attention. Women who are pregnant or planning to become pregnant should not use this medication, and nursing mothers are also advised to avoid it. This medication is not recommended for children under 18 years of age due to insufficient evidence of safety and efficacy.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, pruritus, joint swelling, low back pain, arthritis, muscle spasms, weakness, polyuria, nocturia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disorder, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuropathy, sensory loss, Stevens-Johnson syndrome, dizziness, fatigue, hypotension, reflex tachycardia, non-cardiogenic pulmonary edema
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius.
Dark yellow round film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.